Evotec AG (EVT)

Sector:

Medicine and Biotech Research

Index:

Deutsche Boerse Tec DAX index

€  2.00
   
  • Change Today:
    € -0.13
  • 52 Week High: € 2.93
  • 52 Week Low: € 1.72
  • Currency: Euro
  • Shares Issued: 118.32m
  • Volume: 691,436
  • Market Cap: € 236.99m

Evotec AG Overview

Evotec focuses on the research and devolpment of small molecule drugs. The German based company is split into two segments: Services and Pharmaceuticals. The Services division supplies research support services for pharmaceutical and biotechnology companies. The Pharmaceutical divisions researches treatments for diseases of the Central Nervous System.

1 Day Chart (30-05-2012)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 6.5%
ROCE 9.9%
Latest F'cast
P/E 33.4
PEG 0.3
Pr/Revenue 3.0
Pr/Book 1.6
Latest F'cast
Revenue 45.0%
PBT 35.9%
EPS 100.0%
DPS n/a

Evotec AG Fundamentals

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 32.88 (54.40) (16.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-08 39.61 (75.97) (82.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-09 42.68 (44.82) (43.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-10 55.26 3.87 3.00¢ 97.3 n/a n/a n/a 0.0%
31-Dec-11 80.13 5.26 6.00¢ 38.9 0.4 +100% n/a 0.0%

Evotec AG Forecasts

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 91.67 9.41 8.19¢ 24.4 0.3 +71% n/a 0.0%
31-Dec-13 104.15 13.80 9.68¢ 20.7 1.1 +18% n/a 0.0%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Evotec AG Market Data

Currency Euro
Share Price €  2.00
Change Today €  -0.13
% Change -6.05 %
52 Week High € 2.93
52 Week Low € 1.72
Volume 691,436
Shares Issued 118.32m
Market Cap € 236.99m

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page